Guadalquiver, Agripina L.
HRN: 27-44-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2025
CEFTRIAXONE 1G (VIAL)
07/08/2025
07/16/2025
IV
2g
OD
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: